Small Cap Losers: ATIP, YQ, INMB
2:52 pm Monday, July 26th, 2021
ATI Physical Therapy Inc (NYSE:ATIP) drops to record lows after reporting Q2 results. Results for the quarter were impacted by accelerated attrition among co’s therapists and intensifying competition for clinicians in the labor market, which prevented co from meeting demand and increased its labor costs. Reduced its 2021 forecast. Shares of the company are down 41% to $4.90.
17 Education & Technology Group Inc-ADR (NASDAQ:YQ) continued weakness alongside Chinese tutoring industry peers. Co commented today on the July 24 announcement by China’s official state media of the Opinions on Further Alleviating the Burden of Homework and After-School Tutoring for Students in Compulsory Education; co stated that it will comply with all applicable rules and regulations, including those adopted following the policy directives of the Opinion. It expects compliance measures in connection with the Opinion to have a material adverse impact on its results of operations and prospect. At record lows. The stock slumped 27% to $1.03.
INmune Bio Inc (NASDAQ:INMB) stock decreased 21% to $16.60 after the company announced the design of its upcoming Phase 2 Alzheimer’s disease trial and provided new Phase 1b Alzheimer’s disease trial biomarker data that shows improvement in white matter that degenerate in AD patients. Co is on track to enroll the first patient in the Phase 2 study in Q4.
